Clene Reports Significant Survival Benefit With CNM-Au8 Trea

Clene Reports Significant Survival Benefit With CNM-Au8 Treatment in ALS EAP Compassionate Use Programs

22.02.2024 - Two “Compassionate Use” Expanded Access Programs (EAPs) provided access to treatment with CNM-Au8 to more than 250 people living with amyotrophic lateral sclerosis (ALS).A significant survival benefit (p=0.0001) was observed in EAP participants ... Seite 1

Related Keywords

, Nasdaq , Natural History Consortium , Clene Nanomedicine Inc , Clene Inc , Access Programs , Clene Nanomedicine , Clene Chart , Lene Kurs , Lene Aktie ,

© 2025 Vimarsana